Abstract
Unlabelled
Radiofrequency ablation (RFA) is a potentially curative therapy for hepatocellular carcinoma (HCC). However, incomplete RFA can induce accelerated invasive growth at the periphery. The mechanisms underlying the RFA-induced tumor promotion remain largely unexplored. Three human HCC cell lines were exposed to 45°C-55°C for 10 minutes, simulating the marginal zone of RFA treatment. At 5-12 days post-treatment cell proliferation, parameters of epithelial-mesenchymal transition (EMT), and activation of mitogen-activated protein kinases were analyzed. Livers from patients with viral hepatitis without and with HCC (n = 114) were examined to confirm the relevance of altered kinase patterns. In vivo tumorigenic potential of heat-treated versus untreated HCC cells was studied in nude mice. Heating to 55°C killed all HCC cells, whereas 65%-85% of cells survived 48°C-50°C, developing spindle-like morphology and expressing CD133, cytokeratin (CK)7, CK19, procollagen-α1(I), and Snail at day 5 after heat exposure, which returned to baseline at day 12. Heat-exposed HCC cells showed enhanced proliferation and prominent activation of p46-Shc (Src homology and collagen) and downstream extracellular signal-related kinase (Erk)1/2. In patients, Shc expression correlated with malignant potential and overall survival. Blocking Erk1/2 reduced proliferation and EMT-like changes of heat-treated HCC cells. Implantation of heat-exposed HEPG2 cells into nude mice induced significantly larger, more aggressive tumors than untreated cells.Conclusions
Sublethal heat treatment skews HCC cells toward EMT and transforms them to a progenitor-like, highly proliferative cellular phenotype in vitro and in vivo, which is driven significantly by p46Shc-Erk1/2. Suboptimal RFA accelerates HCC growth and spread by transiently inducing an EMT-like, more aggressive cellular phenotype.Full text links
Read article at publisher's site: https://doi.org/10.1002/hep.26526
Read article for free, from open access legal sources, via Unpaywall: https://aasldpubs.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/hep.26526
References
Articles referenced by this article (50)
Clinical outcomes of radiofrequency ablation, percutaneous alcohol and acetic acid injection for hepatocelullar carcinoma: a meta-analysis.
J Hepatol, (3):380-388 2010
MED: 20149473
Early diffuse recurrence of hepatocellular carcinoma after percutaneous radiofrequency ablation: analysis of risk factors.
Eur Radiol, (1):190-197 2012
MED: 23085860
Risk factors and prognostic factors of local recurrence after radiofrequency ablation of hepatocellular carcinoma.
J Am Coll Surg, (1):20-29 2008
MED: 18589357
Rapid progression of hepatocellular carcinoma after Radiofrequency Ablation.
World J Gastroenterol, (8):1137-1140 2004
MED: 15069713
Hepatocellular carcinoma with sarcomatous change arising after radiofrequency ablation for well-differentiated hepatocellular carcinoma.
Hepatol Res, (2):163-167 2003
MED: 14563432
Rapid and aggressive recurrence accompanied by portal tumor thrombus after radiofrequency ablation for hepatocellular carcinoma.
Int J Clin Oncol, (5):332-335 2003
MED: 14586761
Aggressive recurrence after radiofrequency ablation of liver neoplasms.
Hepatogastroenterology, (54):2179-2184 2003
MED: 14696492
Analysis of recurrence pattern and its influence on survival outcome after radiofrequency ablation of hepatocellular carcinoma.
J Gastrointest Surg, (1):183-191 2007
MED: 17874276
Epithelial-mesenchymal transition in development and cancer: role of phosphatidylinositol 3' kinase/AKT pathways.
Oncogene, (50):7443-7454 2005
MED: 16288291
Show 10 more references (10 of 50)
Citations & impact
Impact metrics
Citations of article over time
Smart citations by scite.ai
Explore citation contexts and check if this article has been
supported or disputed.
https://scite.ai/reports/10.1002/hep.26526
Article citations
Radiofrequency ablation: mechanisms and clinical applications.
MedComm (2020), 5(10):e746, 02 Oct 2024
Cited by: 0 articles | PMID: 39359691 | PMCID: PMC11445673
Review Free full text in Europe PMC
Serum CYFRA 21-1 and CK19-2G2 as Predictive Biomarkers of Response to Transarterial Chemoembolization in Hepatitis C-related Hepatocellular Carcinoma Among Egyptians: A Prospective Study.
J Clin Exp Hepatol, 15(1):102405, 17 Aug 2024
Cited by: 0 articles | PMID: 39309220
Transarterial chemoembolization combined with radiofrequency ablation for medium and large hepatocellular carcinoma: insufficient ablation is associated with intrahepatic distant metastasis and extrahepatic metastasis.
Front Oncol, 14:1283843, 05 Apr 2024
Cited by: 0 articles | PMID: 38646438 | PMCID: PMC11026155
New insights into mechanisms and interventions of locoregional therapies for hepatocellular carcinoma.
Chin J Cancer Res, 36(2):167-194, 01 Apr 2024
Cited by: 1 article | PMID: 38751435 | PMCID: PMC11090796
Melatonin enhances the efficacy of anti-PD-L1 by improving hypoxia in residual tumors after insufficient radiofrequency ablation.
J Pharm Anal, 14(8):100942, 02 Feb 2024
Cited by: 0 articles | PMID: 39263355 | PMCID: PMC11388694
Go to all (84) article citations
Similar Articles
To arrive at the top five similar articles we use a word-weighted algorithm to compare words from the Title and Abstract of each citation.
Incomplete radiofrequency ablation enhances invasiveness and metastasis of residual cancer of hepatocellular carcinoma cell HCCLM3 via activating β-catenin signaling.
PLoS One, 9(12):e115949, 26 Dec 2014
Cited by: 45 articles | PMID: 25542041 | PMCID: PMC4277411
Stress-induced phosphoprotein 1 mediates hepatocellular carcinoma metastasis after insufficient radiofrequency ablation.
Oncogene, 37(26):3514-3527, 21 Mar 2018
Cited by: 30 articles | PMID: 29559743
Extracellular matrix collagen I promotes the tumor progression of residual hepatocellular carcinoma after heat treatment.
BMC Cancer, 18(1):901, 18 Sep 2018
Cited by: 29 articles | PMID: 30227844 | PMCID: PMC6145107
Hepatocellular Carcinoma: Etiology and Current and Future Drugs.
J Clin Exp Hepatol, 9(2):221-232, 25 Jan 2019
Cited by: 128 articles | PMID: 31024205 | PMCID: PMC6477125
Review Free full text in Europe PMC
Funding
Funders who supported this work.
American Liver Foundation, the DFG (2)
Grant ID: SCHM 2661/1-1
Grant ID: 2661/1-2
German Federal Ministry of Education and Research (BMBF; PtJ-Bio) (1)
Grant ID: 0315883
German Research Foundation (DFG) (1)
Grant ID: KO4103/1-1
National Institute of Diabetes and Digestive and Kidney Diseases (2)
Grant ID: 1 R21 DK075857-01A2
Grant ID: U19 AI066313-05